These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 10596013)
21. Direct mapping of MHC class II epitopes. Milosevic S; Behrends U; Christoph H; Mautner J J Immunol Methods; 2005 Nov; 306(1-2):28-39. PubMed ID: 16168435 [TBL] [Abstract][Full Text] [Related]
22. Molecular cloning of the immunodominant regions of hepatitis C virus type III and IV by immunoscreening. Sato A; Kazami J; Arima T; Nakamura H; Kunitomo T Acta Virol; 1993; 37(2-3):132-42. PubMed ID: 7692715 [TBL] [Abstract][Full Text] [Related]
23. A novel hepatitis C virus vaccine approach using recombinant Bacillus Calmette-Guerin expressing multi-epitope antigen. Wei SH; Yin W; An QX; Lei YF; Hu XB; Yang J; Lu X; Zhang H; Xu ZK Arch Virol; 2008; 153(6):1021-9. PubMed ID: 18421415 [TBL] [Abstract][Full Text] [Related]
24. Relation between viral fitness and immune escape within the hepatitis C virus protease. Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887 [TBL] [Abstract][Full Text] [Related]
25. HCV NS3 serine protease-neutralizing single-chain antibodies isolated by a novel genetic screen. Gal-Tanamy M; Zemel R; Berdichevsky Y; Bachmatov L; Tur-Kaspa R; Benhar I J Mol Biol; 2005 Apr; 347(5):991-1003. PubMed ID: 15784258 [TBL] [Abstract][Full Text] [Related]
26. Analysis of human immune response to potential hepatitis C viral epitopes. Khanna A; Poduri CD; Murugan P; Kumar S; Sugunan VS; Shenoy KT; Das MR Acta Virol; 1998 Jun; 42(3):141-5. PubMed ID: 9842443 [TBL] [Abstract][Full Text] [Related]
27. Characterization of a linear epitope in the nonstructural region 4 of hepatitis C virus with reactivity to seroconversion antibodies. Wienhues U; Ihlenfeldt HG; Seidel C; Schmitt U; Kraas W; Jung G Virology; 1998 Jun; 245(2):281-8. PubMed ID: 9636367 [TBL] [Abstract][Full Text] [Related]
28. Exploiting information inherent in binding sites of virus-specific antibodies: design of an HCV vaccine candidate cross-reactive with multiple genotypes. Grollo L; Torresi J; Drummer H; Zeng W; Williamson N; Jackson DC Antivir Ther; 2006; 11(8):1005-14. PubMed ID: 17302370 [TBL] [Abstract][Full Text] [Related]
29. Identification of epitopes in the nucleocapsid protein of Nipah virus using a linear phage-displayed random peptide library. Eshaghi M; Tan WS; Yusoff K J Med Virol; 2005 Jan; 75(1):147-52. PubMed ID: 15543570 [TBL] [Abstract][Full Text] [Related]
30. A highly sensitive and specific enzyme-linked immunosorbent assay of antibodies to hepatitis C virus. Eroglu C; Yildiz E; Ozturk M; Pinarbasi E Acta Virol; 2000 Feb; 44(1):29-33. PubMed ID: 10989689 [TBL] [Abstract][Full Text] [Related]
31. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies. Vietheer PT; Boo I; Drummer HE; Netter HJ Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556 [TBL] [Abstract][Full Text] [Related]
32. Characterization of complex B cell epitopes on woodchuck hepatitis virus surface antigens by using plasmids encoding chimeric proteins and DNA immunization. Zheng X; Schirmbeck R; Hilken G; Waters JA; Yang D; Reimann J; Roggendorf M; Lu M Virology; 2002 Mar; 294(2):342-53. PubMed ID: 12009876 [TBL] [Abstract][Full Text] [Related]
33. The use of epitope arrays in immunodiagnosis of infectious disease: hepatitis C virus, a case study. Siman-Tov DD; Zemel R; Tur Kaspa R; Gershoni JM Anal Biochem; 2013 Jan; 432(2):63-70. PubMed ID: 23017878 [TBL] [Abstract][Full Text] [Related]
34. Epitope mapping of the NS4 and NS5 gene products of hepatitis C virus and the use of a chimeric NS4-NS5 synthetic peptide for serodiagnosis. Rosa C; Osborne S; Garetto F; Griva S; Rivella A; Calabresi G; Guaschino R; Bonelli F J Virol Methods; 1995 Oct; 55(2):219-32. PubMed ID: 8537460 [TBL] [Abstract][Full Text] [Related]
35. [Studies on mimotopes of hepatitis C virus E1 protein]. Cao F; Shi X; Du Y; Hou L; Ji Y; Wang H Zhonghua Gan Zang Bing Za Zhi; 2001 Aug; 9(4):223-5. PubMed ID: 11602054 [TBL] [Abstract][Full Text] [Related]
36. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice. Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486 [TBL] [Abstract][Full Text] [Related]
37. Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection. Guglietta S; Garbuglia AR; Pacciani V; Scottà C; Perrone MP; Laurenti L; Spada E; Mele A; Capobianchi MR; Taliani G; Folgori A; Vitelli A; Ruggeri L; Nicosia A; Piccolella E; Del Porto P Eur J Immunol; 2005 Sep; 35(9):2627-37. PubMed ID: 16114108 [TBL] [Abstract][Full Text] [Related]
39. Bacterial cell surface display for epitope mapping of hepatitis C virus core antigen. Kang SM; Rhee JK; Kim EJ; Han KH; Oh JW FEMS Microbiol Lett; 2003 Sep; 226(2):347-53. PubMed ID: 14553932 [TBL] [Abstract][Full Text] [Related]
40. Broadly cross-reactive mimotope of hypervariable region 1 of hepatitis C virus derived from DNA shuffling and screened by phage display library. Zhang XX; Deng Q; Zhang SY; Liu J; Cai Q; Lu ZM; Wang Y J Med Virol; 2003 Dec; 71(4):511-7. PubMed ID: 14556263 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]